Lilly Seeks Emergency Authorization for Covid Antibody Drug
A health worker injects a person during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, U.S. (Photographer: Eva Marie Uzcategui/Bloomberg)

Lilly Seeks Emergency Authorization for Covid Antibody Drug

(Bloomberg) -- Eli Lilly & Co. asked U.S. drug regulators to authorize emergency use of its experimental Covid-19 antibody therapy after data showed the treatment reduced hospitalizations.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.